首頁 > 市場調查報告書 > 醫療設備

e保健體外診斷藥物開發人工智能人工智能藥物研發診斷用人工智能

市場調查報告書

商品編碼

2126423

人工智慧醫學影像市場：策略性洞察與預測（2026-2035）

AI Medical Imaging Diagnostics Market - Strategic Insights and Forecasts (2026-2035)

出版日期: 2026年08月11日 | 出版商:

Knowledge Sourcing Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計人工智慧醫療影像市場將從 2026 年的 105.8 億美元成長到 2035 年的 341.8 億美元，複合年成長率為 13.9%。

全球人工智慧驅動的醫學影像市場正經歷快速轉型，其驅動力包括影像檢查量的成長、放射科醫生短缺以及醫療保健產業的數位轉型。該市場提供軟體平台和智慧演算法，用於分析醫學影像，幫助臨床醫生檢測異常情況、量化疾病進展並做出實證診斷。它還透過自動化影像解讀和工作流程最佳化，為醫院、影像中心和研究機構提供支援。隨著醫療保健系統採用數位成像技術，資料集規模顯著擴大且日益複雜，從而推動了市場需求。由於放射科醫師必須在有限的時間內仔細審查日益複雜的影像，傳統的影像解讀工作流程在報告方面效率降低。解決方案供應商正在擴展其深度學習、雲端運算和多模態人工智慧平台，以提高診斷可靠性，同時與影像存檔和通訊系統 (PACS) 以及放射資訊系統 (RIS) 無縫整合。隨著醫療保健提供者對可靠且經過臨床檢驗的人工智慧解決方案的需求不斷成長，法律規範、網路安全以及「醫療設備軟體 (SaMD)」的臨床檢驗將繼續影響產品開發。

市場促進因素

對更快速的診斷成像的需求日益成長。

隨著臨床醫生越來越依賴影像學檢查觀察來制定治療策略，醫學影像在疾病診斷中發揮核心作用。隨著醫院放射科處理的檢查數量不斷增加，對人工智慧輔助診斷的需求也日益成長。人工影像解讀雖然增加了病患的需求，但也導致放射科醫師工作量增加，並且由於需要高診斷準確率，報告也出現延誤。技術開發人員正在整合深度學習演算法，以加速影像解讀並優先提取關鍵觀察，同時也開發了自動化分流系統和智慧工作流程管理系統。更快的診斷報告能夠提高臨床效率，並支持更早的治療性介入。

放射學中人工智慧應用的擴展

人工智慧正透過機器學習演算法辨識影像模式，進而改善放射科的工作流程，幫助臨床醫師解讀跨多個疾病領域的影像。隨著醫療機構將人工智慧解決方案應用於乳房攝影篩檢、腫瘤、心血管疾病、神經系統疾病和肌肉骨骼影像等領域，對人工智慧的需求日益成長。傳統的影像解讀方式在擴充性有其局限性，因為放射科醫師必須解讀日益複雜的多模態檢查結果。影像技術公司正在擴展電腦視覺、預測分析和自動病灶檢測功能，以減輕醫生的工作量，同時提高診斷的一致性。人工智慧驅動的解讀透過提高診斷信心和促進工作流程標準化，進而提升醫療品質。

精準醫療和定量診斷影像的擴展

精準醫療依賴客觀的疾病特徵描述，因為個人化治療需要對解剖和功能性影像生物標記進行精確評估。隨著臨床醫生利用定量影像分析來監測疾病進展和治療反應，對人工智慧驅動的診斷的需求日益成長。傳統的定性圖像解讀在可重複性方面存在局限性，因為難以持續量化細微的圖像變異。解決方案供應商正在開發先進的影像分析、放射組學平台和多模態人工智慧，以從複雜的資料集中產生標準化的臨床見解。定量影像診斷透過支援個人化的臨床決策，增強了個人化醫療服務。

醫學影像部門數位轉型進展

隨著醫療保健日益數位化，對智慧影像平台的依賴性也日益增強。這是因為企業影像生態系統需要跨多個臨床系統實現無縫整合。隨著醫院對其PACS、RIS和雲端影像基礎設施進行現代化改造，這種需求不斷成長。傳統的影像環境存在工作流程碎片化的問題，限制了對診斷資訊的有效訪問，並阻礙了互通性。技術供應商正在擴展雲端原生企業影像、人工智慧驅動的工作流程自動化和可互通的醫療保健平台，以提高營運效率和臨床協作。數位轉型透過實現互聯互通、數據驅動的診斷工作流程來增強影像服務。

市場限制因素

將人工智慧成像軟體與現有PACS、RIS和醫院資訊系統整合所面臨的挑戰，持續限制企業級部署。有關臨床檢驗、演算法透明度和網路安全的監管要求，延長了商業化進程。高昂的部署成本、有限的保險報銷以及臨床醫生對演算法可靠性的擔憂，也持續阻礙小規模醫療機構採用該技術。

市場定義和範圍
行業概覽
產業變化
市場規模及預測
主要市場趨勢
AI影像診斷生態系統分析
醫學影像工作流程分析及人工智慧整合
人工智慧模型開發和臨床檢驗的趨勢
放射資訊學和企業影像分析
高精度影像診斷和預測診斷的發展趨勢

第4章市場動態

市場促進因素
市場限制因素
市場機遇
市場挑戰

第5章行業情勢

產業價值鏈分析
供應鏈分析
定價分析
波特五力分析
醫療人工智慧生態系統分析

第6章：創新趨勢

醫學影像中的深度學習
用於診斷成像的電腦視覺
醫學影像中的生成式人工智慧
人工智慧影像重建
基於雲端的影像分析
診斷領域的可解釋人工智慧（XAI）
用於醫學影像診斷的多模態人工智慧和基礎模型

第7章監理情勢

全球法律規範
關於人工智慧驅動的軟體作為醫療設備（SaMD）的法規。
醫學影像的標準化和互通性
關於人工智慧倫理、資料隱私和網路安全的法規

第8章：人工智慧醫學影像診斷市場：展望分析

分析：按影像方式
分析：依部署模式
分析：按最終用戶

第9章：人工智慧醫學影像診斷市場：細分市場分析

透過成像方式
- X光
- 電腦斷層掃描（CT）
- 磁振造影（MRI）
- 超音波
- 核子醫學掃描術診斷（PET/SPECT）
- 乳房X光攝影
部署模式
- 基於雲端的
- 現場
- 混合
最終用戶
- 醫院
- 診斷影像中心
- 學術研究機構
- 門診手術中心（ASC）
- 專科診所

第10章：人工智慧醫學影像診斷市場：區域分析

北美洲
歐洲
亞太地區
拉丁美洲
中東和非洲

第11章：人工智慧醫療影像市場：國別分析

美國
加拿大
德國
英國
法國
義大利
西班牙
荷蘭
瑞士
中國
日本
印度
韓國
澳洲
巴西
沙烏地阿拉伯
南非

第12章競爭格局

市佔率分析
競爭基準
策略趨勢
併購
夥伴關係與合作
產品上市及法規核准

第13章：公司簡介

Siemens Healthineers AG
GE HealthCare Technologies Inc.
Koninklijke Philips NV
Canon Medical Systems Corporation
Fujifilm Holdings Corporation
Aidoc Medical Ltd.
Viz.ai, Inc.
Qure.ai Technologies Pvt. Ltd.
Gleamer SAS
Lunit Inc.
Riverain Technologies
Nanox AI Ltd.
Arterys Inc.
Subtle Medical, Inc.
IBM Corporation

第14章：商業與市場機會分析

人工智慧驅動的放射科工作流程解決方案
人工智慧圖像分析平台
基於雲端的醫學影像人工智慧解決方案
企業影像分析平台
人工智慧在腫瘤影像診斷的應用
人工智慧在心血管影像診斷的應用
人工智慧在神經影像診斷的應用

第15章投資與資金籌措分析

創業投資與私募股權投資
政府對醫療領域人工智慧的資助
研發投資

第16章：未來展望

新興市場的商業機會
未來技術藍圖
分析師建議

簡介目錄

Product Code: KSI-009143

The AI Medical Imaging Diagnostics Market is forecast to grow at a CAGR of 13.9%, reaching USD 34.18 billion in 2035 from USD 10.58 billion in 2026.

The global AI medical imaging diagnostics market is undergoing rapid transformation, driven by the convergence of rising imaging volumes, radiologist shortages, and the digital transformation of healthcare. This market provides software platforms and intelligent algorithms that analyze medical images to assist clinicians in detecting abnormalities, quantifying disease progression, and supporting evidence-based diagnosis. It supports hospitals, diagnostic imaging centers, and research institutions through automated image interpretation and workflow optimization. Demand is increasing as healthcare systems adopt digital imaging technologies, generating substantially larger and more complex datasets. Conventional interpretation workflows reduce reporting efficiency because radiologists must review increasingly complex examinations within constrained timelines. Solution providers are expanding deep learning, cloud computing, and multimodal AI platforms that improve diagnostic confidence while integrating seamlessly with picture archiving and communication systems (PACS) and radiology information systems (RIS). Regulatory oversight for Software as a Medical Device (SaMD), cybersecurity, and clinical validation continues to influence product development, as healthcare providers require trusted and clinically validated AI solutions.

Market Drivers

Rising Demand for Faster Diagnostic Imaging Interpretation

Medical imaging plays a central role in disease diagnosis because clinicians increasingly depend on imaging findings to guide treatment decisions. Demand is shifting toward AI-powered diagnostics as hospitals process higher examination volumes across radiology departments. Manual interpretation creates reporting delays because growing patient demand increases radiologist workload while maintaining high diagnostic accuracy requirements. Technology developers are integrating deep learning algorithms, automated triage systems, and intelligent workflow management that accelerate image interpretation and prioritize critical findings. Faster diagnostic reporting improves clinical efficiency while supporting earlier therapeutic intervention.

Increasing Adoption of Artificial Intelligence in Radiology

Artificial intelligence enhances radiology workflows because machine learning algorithms identify imaging patterns that support clinician interpretation across multiple disease areas. Demand is increasing as healthcare providers deploy AI solutions for chest imaging, oncology, cardiovascular diseases, neurology, and musculoskeletal imaging. Conventional image review limits scalability because radiologists must interpret increasingly complex multimodal examinations. Imaging technology companies are expanding computer vision, predictive analytics, and automated lesion detection capabilities that improve diagnostic consistency while reducing physician workload. AI-assisted interpretation strengthens healthcare quality by improving diagnostic confidence and workflow standardization.

Expansion of Precision Medicine and Quantitative Imaging

Precision medicine depends on objective disease characterization because personalized treatment requires accurate assessment of anatomical and functional imaging biomarkers. Demand is growing for AI diagnostics as clinicians utilize quantitative image analysis to monitor disease progression and treatment response. Traditional qualitative image interpretation limits reproducibility because subtle imaging variations are difficult to quantify consistently. Solution providers are developing advanced imaging analytics, radiomics platforms, and multimodal AI that generate standardized clinical insights from complex datasets. Quantitative imaging strengthens personalized healthcare by supporting individualized clinical decision-making.

Growing Digital Transformation of Imaging Departments

Healthcare digitalization increases dependence on intelligent imaging platforms because enterprise imaging ecosystems require seamless integration across multiple clinical systems. Demand is increasing as hospitals modernize PACS, RIS, and cloud-based imaging infrastructure. Legacy imaging environments restrict interoperability because fragmented workflows limit efficient access to diagnostic information. Technology providers are expanding cloud-native enterprise imaging, AI-enabled workflow automation, and interoperable healthcare platforms that improve operational efficiency and clinical collaboration. Digital transformation strengthens imaging services by enabling connected and data-driven diagnostic workflows.

Market Restraints

Integration challenges between AI imaging software and existing PACS, RIS, and hospital information systems continue limiting enterprise-wide deployment. Regulatory requirements for clinical validation, algorithm transparency, and cybersecurity increase commercialization timelines. High implementation costs, limited reimbursement, and clinician concerns regarding algorithm reliability continue slowing adoption across smaller healthcare facilities.

Technology and Segment Insights

By Imaging Modality

X-ray imaging represents one of the largest application areas because it serves as the primary modality for routine screening, emergency care, and musculoskeletal assessment. Hospitals are adopting AI to improve detection of fractures, pulmonary diseases, and chest abnormalities. Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are significant segments driven by the complexity of cross-sectional imaging and the need for automated lesion detection and quantification. Ultrasound benefits from AI for workflow automation and image optimization. Nuclear imaging (PET/SPECT) and mammography are important segments for oncology and breast cancer screening, where AI enhances detection and risk assessment.

By Deployment Mode

Cloud-based deployment is becoming the preferred model because healthcare organizations require centralized AI services across multiple facilities. Demand is increasing as enterprise imaging networks consolidate data to improve collaboration, scalability, and continuous software updates. Maintaining isolated on-premises infrastructure increases complexity because advanced AI applications require substantial computing resources. Technology providers are expanding secure cloud architectures and subscription-based delivery that simplify deployment. Cloud deployment enables healthcare organizations to scale AI diagnostics efficiently across distributed clinical environments.

By End User

Hospitals represent the largest end-user segment because they perform high volumes of diagnostic imaging supporting emergency medicine, oncology, cardiology, and surgical planning. Demand is increasing as hospital networks integrate AI into enterprise imaging workflows to improve diagnostic accuracy and optimize radiology operations. Diagnostic imaging centers are expanding AI adoption to enhance efficiency and reporting consistency. Academic and research institutes contribute to algorithm development and clinical validation.

Competitive and Strategic Outlook

The competitive landscape features major imaging equipment manufacturers and specialized AI software vendors. Siemens Healthineers AG differentiates itself by combining advanced imaging equipment with AI-enabled software, creating an integrated ecosystem supporting end-to-end radiology workflows. GE HealthCare Technologies Inc. maintains a competitive advantage through its Edison digital health ecosystem enabling AI across radiology. Koninklijke Philips N.V. integrates AI with diagnostic imaging, connected care, and healthcare informatics. Canon Medical Systems Corporation leverages its imaging expertise to expand AI capabilities. Fujifilm Holdings Corporation offers a diversified healthcare portfolio combining imaging systems and AI-driven analysis. Aidoc Medical Ltd. specializes in clinical AI solutions that identify and prioritize critical findings. Viz.ai, Inc. focuses on AI platforms that accelerate care coordination. IBM Corporation provides AI, cloud computing, and enterprise analytics infrastructure.
Strategic developments include increasing integration of generative AI for report generation, expansion of cloud-based enterprise imaging, and development of AI for population screening programs. Companies are forming partnerships to enhance algorithm validation and clinical adoption. Product launches focus on FDA-cleared AI applications, workflow automation tools, and multimodal analytics platforms. Companies that successfully combine validated clinical performance with seamless workflow integration are expected to strengthen their competitive advantage.

Conclusion

The AI medical imaging diagnostics market is poised for substantial growth, driven by rising imaging volumes, radiologist shortages, and the digital transformation of healthcare. The evolution from selective implementation toward routine clinical adoption across major healthcare systems is reshaping radiology practice. Companies that successfully deliver secure, interoperable, and clinically validated AI solutions are expected to lead the market. Ongoing technological innovation, regulatory support, and expanding digital health infrastructure will further accelerate adoption throughout the forecast period.

Key Benefits of this Report

Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2035
Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
Competitive positioning, strategies, and market share evaluation, and trade analysis
Revenue growth and forecast assessment across segments and regions
Company profiling including strategies, products, financials, and key developments

1. Executive Summary

1.1 Market Snapshot
1.2 Key Findings
1.3 Analyst Insights
1.4 Strategic Recommendations

2. Research Methodology

2.1 Research Design
2.2 Primary Research
2.3 Secondary Research
2.4 Market Size Estimation Methodology
2.5 Forecasting Model
2.6 Assumptions & Limitations

3. AI Medical Imaging Diagnostics Market Overview, Size & Forecast

3.1 Market Definition & Scope
3.2 Industry Overview
3.3 Industry Evolution
3.4 Market Size & Forecast (2021-2035)
3.5 Key Market Trends
3.6 AI Imaging Ecosystem Analysis
3.7 Imaging Workflow & AI Integration Analysis
3.8 AI Model Development & Clinical Validation Trends
3.9 Radiology Informatics & Enterprise Imaging Analysis
3.10 Precision Imaging & Predictive Diagnostics Trends

4. Market Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges

5. Industry Landscape

5.1 Industry Value Chain Analysis
5.2 Supply Chain Analysis
5.3 Pricing Analysis
5.4 Porter's Five Forces Analysis
5.5 Healthcare AI Ecosystem Analysis

6. Innovation Landscape

6.1 Deep Learning in Medical Imaging
6.2 Computer Vision for Diagnostic Imaging
6.3 Generative AI in Medical Imaging
6.4 AI-Assisted Image Reconstruction
6.5 Cloud-Based Imaging Analytics
6.6 Explainable AI (XAI) in Diagnostics
6.7 Multimodal AI & Foundation Models for Medical Imaging

7. Regulatory Landscape

7.1 Global Regulatory Framework
7.2 AI-Based Software as a Medical Device (SaMD) Regulations
7.3 Medical Imaging Standards & Interoperability
7.4 AI Ethics, Data Privacy & Cybersecurity Regulations

8. AI Medical Imaging Diagnostics Market Landscape Analysis

8.1 Analysis by Imaging Modality
8.2 Analysis by Deployment Mode
8.3 Analysis by End User

9. AI Medical Imaging Diagnostics Market Segment Analysis (2021-2035)

9.1 By Imaging Modality
- 9.1.1 X-ray
- 9.1.2 Computed Tomography (CT)
- 9.1.3 Magnetic Resonance Imaging (MRI)
- 9.1.4 Ultrasound
- 9.1.5 Nuclear Imaging (PET/SPECT)
- 9.1.6 Mammography
9.2 By Deployment Mode
- 9.2.1 Cloud-Based
- 9.2.2 On-Premises
- 9.2.3 Hybrid
9.3 By End User
- 9.3.1 Hospitals
- 9.3.2 Diagnostic Imaging Centers
- 9.3.3 Academic & Research Institutes
- 9.3.4 Ambulatory Surgical Centers (ASCs)
- 9.3.5 Specialty Clinics